Bernhard Frankenberger

2.4k total citations · 1 hit paper
35 papers, 2.0k citations indexed

About

Bernhard Frankenberger is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Bernhard Frankenberger has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 23 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Bernhard Frankenberger's work include Immunotherapy and Immune Responses (27 papers), Immune Cell Function and Interaction (22 papers) and CAR-T cell therapy research (17 papers). Bernhard Frankenberger is often cited by papers focused on Immunotherapy and Immune Responses (27 papers), Immune Cell Function and Interaction (22 papers) and CAR-T cell therapy research (17 papers). Bernhard Frankenberger collaborates with scholars based in Germany, United States and United Kingdom. Bernhard Frankenberger's co-authors include Dolores J. Schendel, Marion Frankenberger, Löms Ziegler-Heitbrock, Terje Espevik, Farshid Dayyani, Maciej Siedlar, Heike Pohla, Stefani Spranger, Susanne Wilde and Elfriede Noeßner and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Bernhard Frankenberger

34 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF

2002 683 citations Farshid Dayyani, Maciej Siedlar et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Bernhard Frankenberger

Since Specialization

Citations

This map shows the geographic impact of Bernhard Frankenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Frankenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Frankenberger more than expected).

Fields of papers citing papers by Bernhard Frankenberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Frankenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Frankenberger. The network helps show where Bernhard Frankenberger may publish in the future.

Co-authorship network of co-authors of Bernhard Frankenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Frankenberger. A scholar is included among the top collaborators of Bernhard Frankenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Frankenberger. Bernhard Frankenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity 2012 ·OncoImmunology ·Dolores J. Schendel, Bernhard Frankenberger	7
2	NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo 2012 ·Journal of Translational Medicine ·Stefani Spranger, Bernhard Frankenberger, Dolores J. Schendel	38
3	Humanized tumor mice—A new model to study and manipulate the immune response in advanced cancer therapy 2011 ·International Journal of Cancer ·Anja K. Wege, Wolfgang Ernst, (unknown), Bernhard Frankenberger, Arabel Vollmann‐Zwerenz, Daniela N. Männel, Olaf Ortmann, Alexander Kroemer, Gero Brockhoff	86
4	Third generation dendritic cell vaccines for tumor immunotherapy 2011 ·European Journal of Cell Biology ·Bernhard Frankenberger, Dolores J. Schendel	43
5	MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors 2010 ·Journal of Clinical Investigation ·Matthias Leisegang, Susanne Wilde, Stefani Spranger, Slavoljub Milosevic, Bernhard Frankenberger, Wolfgang Uckert, Dolores J. Schendel	72
6	Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation 2010 ·Journal of Translational Medicine ·Maja Bürdek, Stefani Spranger, Susanne Wilde, Bernhard Frankenberger, Dolores J. Schendel, (unknown)	39
7	Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters 2009 ·European Journal of Cancer ·(unknown), Gregor Babaryka, Bernhard Frankenberger, Christian G. Stief, Wolfgang Eisenmenger, Thomas Kirchner, Dolores J. Schendel, Elfriede Noeßner	112
8	Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma 2009 ·Journal of Molecular Medicine ·(unknown), Elfriede Nößner, Bernhard Frankenberger, Christine S. Falk, Heike Pohla, Dolores J. Schendel	9
9	Antitumor effector functions of T cells are dependent on in vivo priming and restricted T‐cell receptor expression 2008 ·International Journal of Cancer ·(unknown), (unknown), Bernhard Frankenberger, (unknown), Martin Röcken, Ralph Mocikat	5
10	A Polyvalent Cellular Vaccine Induces T-cell Responses Against Specific Self-antigens Overexpressed in Chronic Lymphocytic B-cell Leukemia 2008 ·Journal of Immunotherapy ·(unknown), (unknown), Bernhard Frankenberger, (unknown), Martin Dreyling, Michael Hallek, Ralph Mocikat	7
11	Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70 2007 ·Journal of Translational Medicine ·Anke Zobywalski, (unknown), Bernhard Frankenberger, Heike Pohla, Elisabeth Kremmer, Iris Bigalke, Dolores J. Schendel	112
12	Immune suppression in renal cell carcinoma 2007 ·Seminars in Cancer Biology ·Bernhard Frankenberger, Elfriede Noeßner, Dolores J. Schendel	33
13	Activated B Cells Mediate Efficient Expansion of Rare Antigen-Specific T Cells 2007 ·Human Immunology ·(unknown), Martina Wiesner, Stephen Man, Bernhard Frankenberger, Barbara Wollenberg, Peter Hillemanns, Reinhard Zeidler, Wolfgang Hammerschmidt, Andreas Moosmann	12
14	The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients 2004 ·Der Urologe ·Dolores J. Schendel, Christine S. Falk, Bernhard Frankenberger, Elfriede Noeßner, Julia Schleypen, Heike Pohla	1
15	Frequency of Vα24+CD161+ natural killer T cells and invariant TCRAV24-AJ18 transcripts in atopic and non-atopic individuals 2003 ·Immunobiology ·Christine Prell, Nikolaos Konstantopoulos, (unknown), Bernhard Frankenberger, Dietrich Reinhardt, Dolores J. Schendel, Susanne Krauss‐Etschmann	12
16	The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF breakdown → 2002 ·The Journal of Immunology ·(unknown), Farshid Dayyani, (unknown), Maciej Siedlar, Marion Frankenberger, Bernhard Frankenberger, Terje Espevik, Löms Ziegler-Heitbrock	683
17	Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay 2001 ·Nature Medicine ·Christian Becker, Heike Pohla, Bernhard Frankenberger, Thomas Schüler, Mario Assenmacher, (unknown), Thomas Blankenstein	137
18	Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse 2000 ·Gene Therapy ·D. J. Schendel, Bernhard Frankenberger, (unknown), S Cayeux, (unknown), Gerald Willimsky, (unknown), Heike Pohla, T. Blankenstein	33
19	Non-MHC-restricted CD4+ T lymphocytes are regulated by HLA-Cw7-mediated inhibition 2000 ·Human Immunology ·Christine S. Falk, Elfriede Nößner, Bernhard Frankenberger, Dolores J. Schendel	12
20	False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction 1997 ·Lara D. Veeken ·Juha Kirveskari, H. Kellner, Maarit Wuorela, Hanna Soini, Bernhard Frankenberger, Marjatta Leirisalo‐Repo, E. H. Weiss, Kaisa Granfors	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact